Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

co.don

1999 FOUNDED
PUBLIC STATUS
91-100 EMPLOYEES
CNWK STOCK SYMBOL
$4.56 SHARE PRICE (As of Thursday Closing)
Description

co.don AG in cell breeding for the joint-preserving treatment of articular cartilage damage. The company manufactures cell-based biological drugs for the use in orthopedic and neurosurgical applications. Its products are used for the treatment of focal cartilage defects, lumbar disc herniation, non-union fractures and dental disorders.

Website
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Stock Exchange
ETR
Primary Office
  • Warthestra├če 21
  • 14513 Teltow
  • Germany

+49 03328 00000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore co.don’s full profile, request a free trial.

co.don Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$3.37 - $10.36 $88.8M $4.47 -$0.49 16.9K 19.5M

co.don Financials Summary

In Thousands,
USD
TTM
30-Jun-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
FY 2015
31-Dec-2015
Enterprise Value 106,590 154,857 42,653 46,813
Revenue 7,081 6,726 6,192 5,642
EBITDA (9,771) (7,674) (3,769) (2,895)
Net Income (10,077) (7,956) (4,037) (3,179)
Total Assets 32,745 22,734 4,452 8,861
Public Fundamental Data provided by Morningstar, Inc. disclaimer